These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1703332)

  • 81. [Effect of electronic surface properties on interaction between fibrinogen and solid bodies].
    Rzany A; Leistner T; Steiner J; Bolz A; Schaldach M
    Biomed Tech (Berl); 1998; 43 Suppl():388-9. PubMed ID: 9859412
    [No Abstract]   [Full Text] [Related]  

  • 82. Ellipsometry as a tool to study protein films at liquid-solid interfaces.
    Cuypers PA; Hermens WT; Hemker HC
    Anal Biochem; 1978 Jan; 84(1):56-67. PubMed ID: 626380
    [No Abstract]   [Full Text] [Related]  

  • 83. Quantitation of cytoplasmic fibrinogen in rat liver cells.
    Kwan SW; Fuller GM; Krautter MA; van Baval JH; Goldblum RM
    Anal Biochem; 1977 Dec; 83(2):589-96. PubMed ID: 603043
    [No Abstract]   [Full Text] [Related]  

  • 84. Analysis of human fibrinogen by scanning transmission electron microscopy.
    Wall J; Hainfeld J; Haschemeyer RH; Mosesson MW
    Ann N Y Acad Sci; 1983 Jun; 408():164-79. PubMed ID: 6346984
    [No Abstract]   [Full Text] [Related]  

  • 85. Proceedings: Molecular shape of fibrinogen in solution.
    Marguerie G; Stuhrmann H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):572. PubMed ID: 1198463
    [No Abstract]   [Full Text] [Related]  

  • 86. Computer modelling of fibrin assembly.
    Petrov AV; Makogonenko EM
    Ukr Biokhim Zh (1978); 1996; 68(4):25-6. PubMed ID: 9226813
    [No Abstract]   [Full Text] [Related]  

  • 87. The preparation and properties of human fibrinogen of relatively high solubility.
    Mosesson MW; Sherry S
    Biochemistry; 1966 Sep; 5(9):2829-35. PubMed ID: 5961868
    [No Abstract]   [Full Text] [Related]  

  • 88. αIIbβ3 variants in ten families with autosomal dominant macrothrombocytopenia: Expanding the mutational and clinical spectrum.
    Morais S; Oliveira J; Lau C; Pereira M; Gonçalves M; Monteiro C; Gonçalves AR; Matos R; Sampaio M; Cruz E; Freitas I; Santos R; Lima M
    PLoS One; 2020; 15(12):e0235136. PubMed ID: 33276370
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.
    Podolnikova NP; Yakovlev S; Yakubenko VP; Wang X; Gorkun OV; Ugarova TP
    J Biol Chem; 2014 Jan; 289(4):2371-83. PubMed ID: 24338009
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen molecule.
    Yermolenko IS; Gorkun OV; Fuhrmann A; Podolnikova NP; Lishko VK; Oshkadyerov SP; Lord ST; Ros R; Ugarova TP
    J Biol Chem; 2012 Dec; 287(50):41979-90. PubMed ID: 23086938
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen.
    Han J; Baik N; Kim KH; Yang JM; Han GW; Gong Y; Jardí M; Castellino FJ; Felez J; Parmer RJ; Miles LA
    Blood; 2011 Aug; 118(6):1653-62. PubMed ID: 21680799
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Origin of the nonadhesive properties of fibrinogen matrices probed by force spectroscopy.
    Yermolenko IS; Fuhrmann A; Magonov SN; Lishko VK; Oshkadyerov SP; Ros R; Ugarova TP
    Langmuir; 2010 Nov; 26(22):17269-77. PubMed ID: 20883009
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Control of integrin alphaIIb beta3 outside-in signaling and platelet adhesion by sensing the physical properties of fibrin(ogen) substrates.
    Podolnikova NP; Yermolenko IS; Fuhrmann A; Lishko VK; Magonov S; Bowen B; Enderlein J; Podolnikov AV; Ros R; Ugarova TP
    Biochemistry; 2010 Jan; 49(1):68-77. PubMed ID: 19929007
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antiadhesive effect of fibrinogen: a safeguard for thrombus stability.
    Lishko VK; Burke T; Ugarova T
    Blood; 2007 Feb; 109(4):1541-9. PubMed ID: 16849640
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.
    Davis GE; Bayless KJ; Davis MJ; Meininger GA
    Am J Pathol; 2000 May; 156(5):1489-98. PubMed ID: 10793060
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Evidence for novel binding sites on the platelet glycoprotein IIb and IIIa subunits and immobilized fibrinogen.
    Parise LV; Steiner B; Nannizzi L; Criss AB; Phillips DR
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):445-51. PubMed ID: 8424789
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.
    Bunce LA; Sporn LA; Francis CW
    J Clin Invest; 1992 Mar; 89(3):842-50. PubMed ID: 1541676
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Monoclonal antibodies specific for a conformationally altered state of fibrinogen.
    Zamarron C; Ginsberg MH; Plow EF
    Thromb Haemost; 1990 Aug; 64(1):41-6. PubMed ID: 1703332
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
    Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.